{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:49:36Z","timestamp":1782481776299,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["3277"],"award-info":[{"award-number":["3277"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP B83C22003920001"],"award-info":[{"award-number":["CUP B83C22003920001"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["ECS_00000017"],"award-info":[{"award-number":["ECS_00000017"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["1055"],"award-info":[{"award-number":["1055"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108855","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:49:49Z","timestamp":1754495389000},"page":"108855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia"],"prefix":"10.1016","volume":"164","author":[{"given":"Sara","family":"Calenda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Ceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Catarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Varano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Vagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Menicatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Buccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Dal","family":"Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Volpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Capperucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Tanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Landucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Santalmasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cherchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Mazzantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico E.","family":"Pellegrini-Giampietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Colotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108855_bb0005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2025.108855_bb0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/biom13091387","article-title":"Pharmacology of adenosine receptors: recent advancements","volume":"13","author":"Vincenzi","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.108855_bb0015","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/00001756-200004070-00026","article-title":"Are A3 adenosine receptors expressed in the brain?","volume":"11","author":"Rivkees","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.bioorg.2025.108855_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150021","article-title":"Pharmacology of the adenosine A3 receptor in the vasculature and essential hypertension","volume":"11","author":"Ho","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108855_bb0025","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/molecules22040676","article-title":"Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration","volume":"22","author":"Stockwell","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108855_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00395-021-00859-7","article-title":"Adenosine and adenosine receptor-mediated action in coronary microcirculation","volume":"116","author":"Zhang","year":"2021","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11302-022-09884-0","article-title":"A2A adenosine receptor activation prevents neutrophil aging and promotes polarization from N1 towards N2 phenotype","volume":"18","author":"Lov\u00e1szi","year":"2022","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bioorg.2025.108855_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.588757","article-title":"Protective effect of adenosine A2B receptor agonist, BAY60-6583, against transient focal brain ischemia in rat","volume":"11","author":"Dettori","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cns.13190","article-title":"Research progress on adenosine in central nervous system diseases","volume":"25","author":"Liu","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioorg.2025.108855_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/805198","article-title":"Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia","author":"Pedata","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bioorg.2025.108855_bb0055","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/bph.14673","article-title":"Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia-induced brain injury","volume":"176","author":"Zhou","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2015.11.059","article-title":"Role of adenosine A2A receptor in cerebral ischemia-reperfusion injury: signaling to phosphorylated extracellular signal-regulated protein kinase (pERK1\/2)","volume":"314","author":"Mohamed","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioorg.2025.108855_bb0065","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1007\/s12035-023-03909-4","article-title":"Ding exploring Research Trend and hotspots on oxidative stress in ischemic stroke (2001\u22122022): insights from bibliometric","volume":"61","author":"Revi Jiang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116186","article-title":"The role of oxidative stress in blood\u2013brain barrier disruption during ischemic stroke: antioxidants in clinical trials","volume":"228","author":"Lochhead","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117884","article-title":"Targeting RIPK1-mediated necroptosis, oxidative stress, and ferroptosis: a novel multitarget therapy for ischemic stroke","volume":"296","author":"Song","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaneurol.2023.5716","article-title":"Sublingual Edaravone Dexborneol for the treatment of acute ischemic stroke: the TASTE-SL randomized clinical trial","volume":"81","author":"Fu","year":"2024","journal-title":"JAMA Neurol."},{"issue":"62","key":"10.1016\/j.bioorg.2025.108855_bb0085","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1021\/acs.jmedchem.9b00778","article-title":"Antioxidant-conjugated 1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives: highly potent and selective human A2A adenosine receptor antagonists possessing protective efficacy in neuropathic pain","volume":"62","author":"Falsini","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0090","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3390\/ijms25052945","article-title":"Update on antioxidant therapy with Edaravone: expanding applications in neurodegenerative diseases","volume":"25","author":"Yamashita","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108855_bb0095","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2174\/0929867327666200812221022","article-title":"Drug repurposing: promises of Edaravone target drug in traumatic brain injury","volume":"28","author":"Shakkour","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0100","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.STR.0000182241.07096.06","article-title":"Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain","volume":"36","author":"Zhang","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.bioorg.2025.108855_bb0105","first-page":"2437","article-title":"Protective effect of edaravone on blood-brain barrier by affecting NRF-2\/HO-1 signaling pathway","volume":"18","author":"Liu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bioorg.2025.108855_bb0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11011-025-01559-0","article-title":"Edaravone dextranol alleviates ferroptosis, cuproptosis, and blood-brain barrier damage after acute cerebral infarction","volume":"40","author":"Jin","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bioorg.2025.108855_bb0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3565(25)24806-6","article-title":"L-2-Oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human","volume":"257","author":"Porta","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2025.108855_bb0120","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.3390\/ijms13077915","article-title":"L-2-Oxothiazolidine-4-carboxylic acid or \u03b1-lipoic acid attenuates airway remodeling: involvement of nuclear factor-kB (NF-kB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and hypoxia-inducible factor (HIF)","volume":"13","author":"Park","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108855_bb0125","first-page":"73","article-title":"L-2-oxothiazolidine-4-carboxylic acid attenuates oxidative stress and inflammation in retinal pigment epithelium","volume":"20","author":"Promsote","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.bioorg.2025.108855_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12975-019-00707-w","article-title":"Therapeutic role of a cysteine precursor, OTC, in ischemic stroke is mediated by improved proteostasis in mice","volume":"11","author":"Liu","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.bioorg.2025.108855_bb0135","first-page":"16","article-title":"Cysteine donor-based brain-targeting prodrug: opportunities and challenges oxidative","volume":"4834117","author":"Ni","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bioorg.2025.108855_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117538","article-title":"L-cysteine mitigates ROS-induced apoptosis and neurocognitive deficits by protecting against endoplasmic reticulum stress and mitochondrial dysfunction in mouse neuronal cells","volume":"180","author":"Park","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108855_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bioorg.2019.03.046","article-title":"Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against \u03b2-amyloid-induced neurotoxicity in SH-SY5Y cells","volume":"87","author":"Falsini","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0150","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1021\/acs.orglett.1c01013","article-title":"Tyrosine-specific modification via a dearomatization-rearomatization strategy: access to azobenzene functionalized peptides","volume":"23","author":"Wang","year":"2021","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108855_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127126","article-title":"New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists","volume":"30","author":"Falsini","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108855_bb0160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/jm8007008","article-title":"Edaravone derivatives containing NO-donor functions","volume":"52","author":"Chegaev","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jhet.5570240128","article-title":"Synthesis and reaction of 4-isopropylidene-1-aryl-3-methyl-2-pyrazolin-5-ones","volume":"24","author":"DeRuiter","year":"1987","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/jhet.5570430408","article-title":"Synthesis of acyl-1,2-dihydro-3H-pyrazol-3-ones via Lewis acid-mediated rearrangement of 3-acyloxypyrazoles","volume":"43","author":"Maruoka","year":"2006","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0175","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1002\/chem.200400733","article-title":"A practical synthesis of (+) biotin from L-cysteine","volume":"10","author":"Seki","year":"2004","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2025.108855_bb0180","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1007\/s13197-015-1931-z","article-title":"A high correlation indicating for an evaluation of antioxidant activity and total phenolics content of various chilli varieties","volume":"52","author":"Sricharoen","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2016.03.017","article-title":"Synthesis and characterization of brain penetrant prodrug of neuroprotective D-264: potential therapeutic application in the treatment of Parkinson\u2019s disease","volume":"103","author":"Dholkawala","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioorg.2025.108855_bb0190","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-017-00630-4","article-title":"Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons","volume":"8","author":"Weinert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108855_bb0195","series-title":"C.C.G., Inc., 1255 University St., Suite 1600, Montreal, Quebec, Canada, H3B 3X3","author":"Molecular Operating Environment","year":"2025"},{"key":"10.1016\/j.bioorg.2025.108855_bb0200","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0205","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.str.2017.06.012","article-title":"Structures of human A1 and A2A adenosine receptors with xanthines reveal determinants of selectivity","volume":"25","author":"Cheng","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2025.108855_bb0210","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1038\/s41467-024-47207-6","article-title":"Cryo-EM structures of adenosine receptor A3 AR bound to selective agonists","volume":"15","author":"Cai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108855_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106865","article-title":"Dual action of sphingosine 1-phosphate pathway in in vitro models of global cerebral ischemia","volume":"208","author":"Mazzantini","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioorg.2025.108855_bb0220","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.bjp.0706646","article-title":"A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro","volume":"147","author":"Pugliese","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"157","key":"10.1016\/j.bioorg.2025.108855_bb0225","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1476-5381.2009.00218.x","article-title":"The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices","volume":"157","author":"Pugliese","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108855_bb0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vascn.2010.10.004","article-title":"Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants","volume":"63","author":"Sanmart\u00edn-Su\u00e1rez","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bioorg.2025.108855_bb0235","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.foodchem.2012.11.001","article-title":"EC50 estimation of antioxidant activity in DPPH assay using several statistical programs","volume":"138","author":"Zheng","year":"2013","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2025.108855_bb0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/ph16020167","article-title":"Dual anta-inhibitors of the A2A adenosine receptor and casein kinase CK1delta: synthesis, biological evaluation, and molecular modeling studies","volume":"16","author":"Spinaci","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108855_bb0245","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/biom13060894","article-title":"Pharmacological characterization of P626, a novel dual adenosine A2A\/A2B receptor antagonist, on synaptic plasticity and during an ischemic-like insult in CA1 rat hippocampus","volume":"13","author":"Venturini","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.108855_bb0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"108","author":"Anderson","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bioorg.2025.108855_bb0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.jcbfm.9600569","article-title":"Direct, live imaging of cortical spreading depression and anoxic depolarization using a fluorescent, voltage-sensitive dye","volume":"28","author":"Farkas","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bioorg.2025.108855_bb0260","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.3390\/cells11193015","article-title":"The neuroprotective effects of mGlu1 receptor antagonists are mediated by an enhancement of GABAergics transmission via a presynaptic CB1 receptor mechanism","volume":"11","author":"Landucci","year":"2022","journal-title":"Cells"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:33:19Z","timestamp":1762223599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825007357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"alternative-id":["S0045206825007357"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108855","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108855"}}